Real-World Data on Prognostic Factors for Overall Survival in EGFR-Mutant Non-Small-Cell Lung Cancer Patients with Brain Metastases

Background: With the wide application of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), the survival of EGFR-mutant non-small-cell lung cancer (NSCLC) patients with brain metastasis (BM) has been significantly improved. However, prognosis analysis for patients with EGFR mut...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xiaoqing, Fan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603428/
https://www.ncbi.nlm.nih.gov/pubmed/31293653
http://dx.doi.org/10.7150/jca.30292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603428/
https://www.ncbi.nlm.nih.gov/pubmed/31293653
http://dx.doi.org/10.7150/jca.30292

Ejemplares similares